Two-Year Follow-up Study on Children Exposed to Trauma (Complex PTSD)
Descripción general del estudio
Estado
Descripción detallada
This study will be conducted under the coordination of Istanbul Faculty of Medicine, Department of Child and Adolescent Psychiatry. Children and adolescents between the ages of 7-18 who have been exposed to trauma and who applied to the Child and Adolescent Psychiatry outpatient clinic of Istanbul Faculty of Medicine and who were evaluated within the scope of the thesis study two year ago (January-April 2024) and one year ago (January-June 2025), will be re-evaluated two year later. It is aimed to reach all 136 children and adolescents and evaluate those who agree to participate in the study.
Sample:
Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study two year ago (January-April 2024) and re-evaluated by a doctor a year ago; Children and adolescents aged 7-18, Children and/or parents with adequate literacy and Turkish language skills, Those without psychotic/manic symptoms or a diagnosis of autism spectrum disorder or intellectual disability in the child or parent during the interview, Volunteers who agree to participate in the study. Researchers will explain the study to volunteer children and their families and present the Informed Consent Form to determine their willingness to participate.
Parents of eligible volunteers will complete the following assessments:
- Sociodemographic Data Form
- Brief Psychological Resilience Scale
- Pittsburgh Sleep Quality Index
- Mood Disorders and Schizophrenia Interview Schedule for School-Aged Children (MAS-S)
- International Trauma Scale - Child and Adolescent Version
- Children's Anxiety and Depression Scale - Revised
- UCLA Post-Traumatic Stress Disorder Reaction Index for DSM-5
- Children's General Assessment Scale
- ICD-11-based clinical interview
The start date for the study is March 2026, and data analysis will commence afterward. Data will be analyzed using the Statistical Program for Social Sciences (SPSS for Windows, version 21.0). The study is expected to be completed by October 2026
The coordinating center responsible for the research is the Department of Child and Adolescent Psychiatry at Istanbul Faculty of Medicine.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Fatih
-
Istanbul, Fatih, Turquía (Türkiye), 34116
- İstanbul Esnaf Hastanesi
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study two year ago (January-April 2024), and one year ago (January-June 2025), Children and adolescents aged 7-18, Children and/or parents with adequate literacy and Turkish language skills.
Exclusion Criteria:
- The presence of psychotic/manic symptoms in the child or parent during the interview or any condition that makes the interview and assessment impossible (e.g., mental or developmental condition or a different communication language), The child or parent refusing to participate in the study, The presence of autism spectrum disorder or intellectual disability at a severity that prevents assessment.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
children who had at least one trauma two years ago
Inclusion Criteria: Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study two year ago (January-April 2024), and one year ago (January-June 2025), Children and adolescents aged 7-18, Children and/or parents with adequate literacy and Turkish language skills. Exclusion Criteria: The presence of psychotic/manic symptoms in the child or parent during the interview or any condition that makes the interview and assessment impossible (e.g., mental or developmental condition or a different communication language), The child or parent refusing to participate in the study, The presence of autism spectrum disorder or intellectual disability at a severity that prevents assessment. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Prevalence of PTSD and Complex PTSD in Children and Adolescents Exposed to Trauma
Periodo de tiempo: from january 2024 to august 2026
|
This study, as part of thesis research, aims to investigate the prevalence of PTSD and CPTSD diagnoses two years after the initial evaluation in trauma-exposed children and adolescents evaluated in our outpatient clinic between January-April 2024 and January-June 2025.
|
from january 2024 to august 2026
|
|
Factors Associated with the Diagnosis of PTSD and Complex PTSD
Periodo de tiempo: from march 2026 to august 2026
|
We aim to investigate the correlations between PTSD, CPTSD diagnoses and various clinical measures, such as the child's PTSD symptom severity assessed by the UCLA RI-5, psychological resilience, sleep routines, and anxiety/depression severity
|
from march 2026 to august 2026
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Orengul AC, Kucukardali RS, Karal BN, Gormez V. Psychometric Assessment of the UCLA PTSD Reaction Index for DSM-5 Brief Form in a Clinical Sample of Turkish Youth. Child Psychiatry Hum Dev. 2025 Aug 13. doi: 10.1007/s10578-025-01905-4. Online ahead of print.
- Kucukardali RS, Karal BN, Steinberg AM, Orengul AC. Psychometric evaluation of the UCLA PTSD Reaction Index (PTSD RI-5) in a Turkish Clinical sample of trauma-exposed children. Eur J Psychotraumatol. 2025 Dec;16(1):2465082. doi: 10.1080/20008066.2025.2465082. Epub 2025 Feb 24.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2026/470
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .